A great choice for COVID-19 gains

PFIZER INC. $37 is a buy. The company (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.6 billion; Market cap: $207.2 billion; Price-to-sales ratio: 4.1; Dividend yield: 4.1%; TSINetwork Rating: Above Average; www.pfizer.com) saw its revenue in the first quarter of 2020 fall 8.3%,… Read More

It’s offering you a COVID upside

PFIZER INC. $36 is a buy. The company (New York symbol PFE; Income Portfolio, Manufacturing & Industry sector; Shares outstanding: 5.55 billion; Market cap: $199.8 billion; Dividend yield: 4.2%; Dividend Sustainability Rating: Highest; www.pfizer.com) is one of the world’s largest makers of prescription drugs. Its top-selling brands include Lyrica… Read More